DUNIA MIRANDA: Open Payments
NPI 1699545327 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 86 payments from 15 companies in 2025. Trend: 2023 $23 · 2024 $1,024 · 2025 $1,585
Food & beverage: $1,405Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $436 |
| UCB, Inc. | 12 | $214 |
| Janssen Biotech, Inc. | 8 | $207 |
| Lilly USA, LLC | 13 | $160 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $136 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Amgen Inc. | 3 | $52 |
| Galderma Laboratories, L.P. | 3 | $48 |
| GENZYME CORPORATION | 3 | $42 |
Products named: SKYRIZI, Bimzelx, TREMFYA, RINVOQ, TALTZ, DUPIXENT, COSENTYX, ILUMYA.
Industry payments across NE — which companies pay providers there.
